Search Count: 8
 |
Plasmodium Falciparum Dihydroorotate Dehydrogenase In Complex With 3-Hydroxy-1-Methyl Pyrazole Derivatives
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:2.95 Å Release Date: 2026-04-01 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, A1JWR |
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2026-04-01
Ligands: FMN, ORO, A1JWR
 |
Plasmodium Falciparum Dihydroorotate Dehydrogenase In Complex With 3-Hydroxy-1-Methyl Pyrazole Derivatives
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2026-04-01 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, A1JWQ |
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2026-04-01
Ligands: FMN, ORO, A1JWQ
 |
Structure Of Aldo-Keto Reductase 1C3 (Akr1C3) In Complex With An Inhibitor M689, With The 3-Hydroxy-Benzoisoxazole Moiety. Resolution 2.0A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-03-06 Classification: OXIDOREDUCTASE Ligands: NAP, YMC, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-03-06
Ligands: NAP, YMC, EDO
 |
Crystal Structure Of Human Dihydroorotate Dehydrogenase In Complex With The Inhibitor 2-Hydroxy-N-(2-Ispropyl-5-Methyl-4-Phenoxyphenyl)Pyrazolo[1,5-A]Pyridine-3-Carboxamide.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2022-10-12 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, IEQ, P6G, ACT |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-10-12
Ligands: FMN, ORO, IEQ, P6G, ACT
 |
Crystal Structure Of Aldo-Keto Reductase 1C3 (Akr1C3) Complexed With Inhibitor.
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2019-05-08 Classification: OXIDOREDUCTASE Ligands: NAP, FFW, EDO |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2019-05-08
Ligands: NAP, FFW, EDO
 |
Plasmodium Falciparum Dihydroorotate Dehydrogenase (Dhodh) Co-Crystallized With 3-Hydroxy-1-Methyl-5-((3-(Trifluoromethyl)Phenoxy)Methyl)-1H-Pyrazole-4-Carboxylic Acid
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2018-12-19 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, E2N |
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2018-12-19
Ligands: FMN, ORO, E2N
 |
Plasmodium Falciparum Dihydroorotate Dehydrogenase (Dhodh) Co-Crystallized With N-(2,2-Diphenylethyl)-4-Hydroxy-1,2,5-Thiadiazole-3-Carboxamide
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2018-12-19 Classification: OXIDOREDUCTASE Ligands: FMN, ORO, DZB |
Organism: Plasmodium falciparum
Method: X-RAY DIFFRACTION
Release Date: 2018-12-19
Ligands: FMN, ORO, DZB
 |
Targeting Myeloid Differentiation Using Potent Human Dihydroorotate Dehydrogenase (Hdhodh) Inhibitors Based On 2-Hydroxypyrazolo[1,5-A]Pyridine Scaffold
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.58 Å Release Date: 2018-07-11 Classification: OXIDOREDUCTASE Ligands: DUH, CL, FMN, ACT, ORO, GOL, PGE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-07-11
Ligands: DUH, CL, FMN, ACT, ORO, GOL, PGE